ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Washington, DC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Breast Cancer
Cancer
Ovarian Cancer
Neoplasm Metastasis
Non-Small-Cell Lung Carcinoma
Colorectal Cancer

Prostate Cancer trials near Washington, DC, USA:

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

plus valacyclovir in men with localized, intermediate-risk prostate cancer who are planning to receive external beam radiation ther...

Enrolling
Prostate Cancer Patients Treated by Radiotherapy
Prostate Cancer (Adenocarcinoma)
Biological: aglatimagene besadenovec + valacyclovir
Radiation: External Beam Radiation Therapy (EBRT)

Phase 2

Candel Therapeutics

Towson, Maryland, United States and 6 other locations

Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, pros...

Active, not recruiting
Localized Prostate Cancer
Device: Aquablation Therapy
Procedure: Radical Prostatectomy
PROCEPT BioRobotics

Alexandria, Virginia, United States and 38 other locations

Locations recently updated

and in combination with abiraterone in participants with metastatic prostate cancer. The study includes dose-escalation and cohort ...

Active, not recruiting
Prostate Cancer Metastatic
Drug: Corticosteroid (e.g., prednisone/prednisolone)
Drug: Abiraterone

Phase 1, Phase 2

Novartis
Novartis

Fairfax, Virginia, United States and 16 other locations

This Phase 2, open-label, multicenter study is conducted in patients with castration-resistant prostate cancer.Patients in this stu ...

Enrolling
Prostate Cancer (Adenocarcinoma)
Castration-Resistant Prostate Cancer
Drug: Oral MRT-2359
Drug: Apalutamide

Phase 2

Monte Rosa Therapeutics

Fairfax, Virginia, United States and 13 other locations

pharmacokinetic (PK), pharmacodynamic (PD), and the preliminary efficacy of JANX007 in adults with metastatic castration-resistant prostate ...

Enrolling
Castration Resistant Prostatic Cancer
Metastatic Castration-resistant Prostate Cancer
Biological: JANX007
Drug: Darolutamide

Phase 1

Janux Therapeutics

Baltimore, Maryland, United States and 35 other locations

The main purpose of this study is to assess the safety and tolerability of AZD0516 as monotherapy and/or in combination with other anti-cancer...

Enrolling
Metastatic Prostate Cancer
Drug: AZD9574
Drug: AZD0516

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Towson, Maryland, United States and 51 other locations

Asymptomatic patients with metastatic castrate resistant prostate cancer (mCRPC) without pain due to prostate cancer...

Enrolling
Prostate Cancer
Drug: Enzalutamide
Drug: Luteinizing hormone-releasing hormone (LHRH) analogue

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Baltimore, Maryland, United States

The study will be conducted in 4 parts and will commence with dose escalation of VIR-5500 as a monotherapy (Part 1), followed by combination escalati...

Enrolling
Hormone-refractory Prostate Cancer
Combination Product: ARSI
Drug: VIR-5500

Phase 1

Vir Biotechnology

Fairfax, Virginia, United States and 11 other locations

Medicines that reduce the amount of testosterone in the body are commonly used to treat prostate cancer. PRL-02 depot is a potentia ...

Enrolling
Metastatic Castration Resistant Prostate Cancer
Metastatic Castration-sensitive Prostate Cancer
Drug: prednisone
Drug: PRL-02 injection

Phase 1

Astellas
Astellas

Bethesda, Maryland, United States and 25 other locations

The purpose of this study is to evaluate the effectiveness of CAN-2409 immunotherapy in patients undergoing active surveillance for localized prostate...

Active, not recruiting
Prostate Cancer
Biological: placebo
Drug: valacyclovir

Phase 2

Candel Therapeutics

Bethesda, Maryland, United States and 22 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems